Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

布洛芬混悬液 - NMPA Drug Approval Details

Approvals/NMPA/Ibuprofen Suspension

Approved

化学药品

Ibuprofen Suspension

海南万玮制药有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 30, 2022
Approval ID: 700e8ce2ba71feb8
Company: 海南万玮制药有限公司
Type: 化学药品

Approval Details

Approval Id: 700e8ce2ba71feb8
Approval Number: 国药准字H20223975
Generic Name: 布洛芬混悬液
Generic Name En: Ibuprofen Suspension
Drug Type: 化学药品
Dosage Form: 口服混悬剂
Strength: 100ml:2g
Reg Date: 2022-12-30
Company Name: 海南万玮制药有限公司
Company Address: 海南省海口市南海大道100号美国工业村2号厂房
Production Company Name: 海南万玮制药有限公司;江苏万高药业股份有限公司
Production Company Address: 海南省海口市南海大道100号美国工业村2号厂房口服液体制剂车间口服混悬剂生产线；江苏省海门经济技术开发区定海路688号202车间口服混悬剂生产线
Company Detail Path: /organization/3608d07a081dab17/hai-nan-mo-wei-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 30, 2022

Approval ID

700e8ce2ba71feb8

Type

化学药品

Back to NMPA Approvals